Amgen, Inc. (AMGN) Tops Q2 EPS by 30c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Alaska LNG shipping savings justifies billions in investment, developer says
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
Amgen (AMGN) PT Raised to $135 at BMO Capital
July 30, 2014 9:11 AM EDTBMO Capital analyst Jim Birchenough reiterated a Market Perform rating and bumped his price target on Amgen (NASDAQ: AMGN) to $135.00 (from $125.00) following Q2 results
Birchenough comments, "While AMGN continues to execute well on generating a return from legacy products, we believe that transformational growth... More
Amgen (AMGN) PT, Estimates Raised at Piper Jaffray Following 'Robust' Q2
July 30, 2014 9:07 AM EDTPiper Jaffray analyst Joshua Schimmer reiterated an Overweight rating and boosted his price target on Amgen (NASDAQ: AMGN) to $150.00 (from $143.00) following "robust" Q2 results after the close.
Schimmer comments, "AMGN reported a robust 2Q after the close, with total revenue of $5.18B... More



